The alpha chain of the human interleukin-3 receptor (IL-3Rα), also known as CD123, is frequently overexpressed in several hematological malignancies, including AML where it is expressed on blasts from patients (77,9%) and LSCs (80,7%) (Ehninger et al., 2014). This evidence concerns the gene IL3RA and acute myeloid leukemia.